Search Within

Eric Jurgens

Formats
  1. Meeting Abstract (13)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. GME, Medicine (15)
  2. Graduate Medical Education (15)
  3. Hematology-Oncology Fellows (15)
  4. Bone Marrow Transplant (14)
  5. CTCR Scholars (14)
  6. Center for Hematologic Malignancies (14)

More Groups

People
  1. Saad Usmani (15)
  2. Alexander Lesokhin (14)
  3. Carlyn Rose Tan (14)
  4. David Chung (14)
  5. Hani Hassoun (14)
  6. Heather Landau (14)

More People

Years
  1. 2025 (1)
  2. 2024 (13)
  3. 2023 (1)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (8)
  2. Blood (6)
  3. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (8)
  2. American Society of Hematology (6)
  3. American Society of Clinical Oncology (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Rajeeve, S.; Jurgens, E.; Nishimura, N.; Farzana, T.; Firestone, R.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Tan, C.; Shekarkhand, T.; Firestone, R.; Jurgens, E.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; Rajeeve, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • SOHO state of the art updates and next questions: Will CAR-T replace ASCT in NDMM
    Review

    Jurgens, E.; Usmani, S. Z.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save